Condition: Myocardial Infarct · Sponsor: Vastra Gotaland Region
The objective of this trial is to examine the effect of immediate versus late administration of beta blockers, angiotensin converting enzyme inhibitors (ACEI), and sodium/glucose cotransporter 2 (SGLT2) inhibitors on echocardiographic parameters and biomarkers in subjects with ST-elevation myocardial infarction (STEMI)
This description comes directly from the study's public registry record.
Björn Redfors, Professor · +46 31342100 · bjoern.redfors@wlab.gu.se
Margareta Scharin Täng, PhD · 0736916467 · margareta.scharin.tang@vgregion.se
Always discuss trial participation with your own doctor first.
| Sahlgrenska University Hospital | Gothenburg, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06562582